SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Vaccine
Vaccine
Page 9 of 12
Newsletters
The tech-stock bulls are back
By
Bernhard Warner
September 16, 2020
Health
China’s controversial emergency-use program for COVID vaccines is going global
By
Grady McGregor
September 16, 2020
Newsletters
Is M&A back? Investors hope so, and that’s lifting global stocks
By
Bernhard Warner
September 15, 2020
Newsletters
A flurry of M&A deals lifts global stocks. Yes, even tech stocks
By
Bernhard Warner
September 14, 2020
International
AstraZeneca’s COVID-19 vaccine is back on track after getting the green light to resume trials in the U.K.
By
Stephanie Baker
and
Bloomberg
September 13, 2020
Newsletters
The future of the call center
By
David Meyer
and
Alan Murray
September 11, 2020
International
When will a COVID vaccine be ready? The fourth quarter or early 2021, top Chinese vaccine executive says
By
Grady McGregor
September 11, 2020
Health
COVID-19 vaccine still on track for later this year despite trial pause, AstraZeneca CEO says
By
Jeremy Kahn
September 10, 2020
Newsletters
Pfizer’s Albert Bourla: Vaccine efforts are improving Big Pharma’s reputation
By
David Meyer
and
Alan Murray
September 10, 2020
Newsletters
Global markets dip as investors again sour on tech stocks
By
Bernhard Warner
September 10, 2020
International
Scientists see an upside to AstraZeneca halting its COVID-19 vaccine trial
By
Grady McGregor
September 9, 2020
Newsletters
Global stocks climb—and futures jump—after Tuesday’s sell-off
By
Bernhard Warner
September 9, 2020
Newsletters
Why last week’s great tech sell-off should make investors wary
By
Bernhard Warner
September 8, 2020
International
A Chinese vaccine maker is injecting employees and their families with its COVID-19 candidate
By
Grady McGregor
September 7, 2020
Health
Trump wants a COVID-19 vaccine by Election Day. But will one be ready?
By
Jeremy Kahn
September 4, 2020
Most Popular
Retail
Walmart and Target are allegedly forcing employees to remove tags on apparel to make it easier to jack up prices based...
By
Erin Cabrey
and
Retail Brew
Economy
Ray Dalio says 'most people are silent' because they're afraid to talk about what's really happening with the U.S....
By
Dave Smith
Success
Unemployed graduates are flocking to this business degree to stand out in the current job market. Unlike most MBAs it...
By
Emma Burleigh